글로벌 수술 부위 감염 관리 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

수술 부위 감염 관리 시장 분석

수술 부위 감염(SSI) 관리 시장은 감염 예방에 대한 인식 증가와 의료 기술의 발전으로 인해 빠르게 진화하고 있습니다. 수술 절차의 증가와 환자 안전에 대한 집중 증가로 인해 주도되는 이 시장에는 항균 봉합사, 감염 예방 솔루션, 수술용 드레이프와 같은 제품이 포함됩니다. 주요 개발에는 수술 도구에 고급 항균 재료를 통합하고 혁신적인 살균 기술을 사용하여 감염 관리를 강화하는 것이 포함됩니다. 회사는 보다 효과적인 SSI 예방 제품을 개발하고 기존 기술을 개선하기 위해 연구에 투자하고 있습니다. 또한 병원에서 발생하는 감염의 증가로 인해 엄격한 규제와 감염 관리 프로토콜 채택이 증가했습니다. 이러한 요인은 시장 성장과 혁신을 촉진하여 수술 환경에서 더 나은 결과와 감소된 감염률을 가져올 것으로 예상됩니다.

수술 부위 감염 관리 시장 규모

글로벌 수술 부위 감염 관리 시장 규모는 2023년에 59억 2,000만 달러로 평가되었으며, 2031년까지 95억 7,000만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 6.19%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

수술 부위 감염 관리 시장 동향

“ 첨단 항균 코팅 및 기술 도입”

수술 부위 감염(SSI) 제어 시장은 환자 안전을 강화하고 수술 결과를 개선하는 데 중점을 두면서 빠르게 진화하고 있으며, 이는 수술 도구와 의료 기기에 대한 고급 항균 코팅 및 기술의 채택 추세에서 두드러집니다. 이러한 혁신적인 솔루션은 광범위한 병원균에 대한 지속적인 보호를 제공하여 감염 위험을 최소화하는 것을 목표로 합니다. 예를 들어, 은이온 항균 코팅은 수술 도구의 박테리아 식민지화를 줄이는 데 효과가 입증되어 SSI 비율을 낮춥니다. 이러한 추세는 감염 제어 프로토콜을 강화하고 전반적인 환자 치료를 개선하기 위해 최첨단 소재와 기술을 수술 관행에 통합하는 방향으로 더 광범위하게 전환되고 있음을 반영합니다. 의료 시설이 엄격한 감염 제어 표준을 충족하고 의료 관련 감염을 줄이기 위해 이러한 고급 솔루션에 투자함에 따라 시장은 상당한 성장을 목격하고 있습니다.

보고서 범위 및 수술 부위 감염 관리 시장 세분화         

Surgical Site Infection Control Market Definition

Surgical Site Infection (SSI) Control refers to the strategies and practices implemented to prevent infections at the site of a surgical procedure. Strategies and practices encompasses a range of measures, including preoperative sterilization and antiseptic protocols, the use of prophylactic antibiotics, sterile surgical techniques, and post-operative wound care. Effective SSI control aims to reduce the incidence of infections, promote faster healing, and improve overall surgical outcomes by maintaining a clean and safe environment throughout the surgical process.

Surgical Site Infection Control Market Dynamics

Drivers

• Increasing Number Of Surgical Procedures

The increasing number of surgical procedures globally is a significant driver for the SSI control market. According to the World Health Organization (WHO), approximately 234 million major surgical procedures are performed annually worldwide. This surge in surgical activities correlates with a higher risk of infections, emphasizing the need for effective SSI control measures. The growing volume of surgeries, both elective and emergency, amplifies the demand for advanced infection control technologies and protocols to mitigate these risks and improve patient outcomes. Such a trend underscores the critical role of effective SSI prevention strategies in managing the growing burden associated with surgical interventions.

• Innovations in Antimicrobial Technologies

Innovations in antimicrobial technologies are revolutionizing infection prevention in surgical settings, providing more robust and targeted solutions to combat SSIs. Antimicrobial coatings for surgical instruments, such as those incorporating silver or iodine, effectively inhibit microbial growth on surfaces, drastically reducing the risk of infections. Advanced wound dressings, such as those embedded with bioactive agents such as honey or antimicrobial peptides, offer sustained protection and accelerate healing. Additionally, new antiseptic solutions, including formulations with enhanced concentrations of chlorhexidine gluconate, offer superior efficacy in preoperative skin disinfection. Such advancements collectively enhance infection control measures, leading to improved patient outcomes and reduced healthcare-associated complications. Consequently fostering the surgical site infection control market.

Opportunities

• Increased Focus on Patient Safety

The heightened focus on patient safety has significantly influenced the investment in SSI prevention technologies and practices. According to the Patient Safety Network - Agency for Healthcare Research and Quality, more than one million Healthcare-associated infections (HAIs) occur across the United States healthcare system every year. Such alarming statistics has led to a strong emphasis on improving the quality of care, prompting healthcare facilities to invest in advanced SSI prevention measures. For instance, hospitals that have implemented comprehensive infection control programs, including the use of advanced antimicrobial technologies and rigorous preoperative protocols. Furthermore, the Centers for Disease Control and Prevention (CDC) supports these efforts through its guidelines and initiatives aimed at enhancing infection prevention practices, thereby reinforcing the commitment to safeguarding patient health ,thus creating significant opportunities in the innovative SSI control solutions.

• Wearable Technologies Enhancing Surgical Site Infection Control

Wearable technologies designed to monitor and analyze infection risks in real-time present a significant opportunity in the surgical site infection (SSI) control market. For instance, the TempTraq wearable temperature monitoring patch continuously tracks body temperature and transmits data to healthcare providers. Wearable improvised devices can detect deviations from normal temperature ranges, potentially indicating an infection, and promptly alert medical staff. Research has demonstrated that early detection through such wearables can lead to earlier treatment interventions, significantly reducing the risk of complications and hospitalizations. As healthcare facilities increasingly focus on reducing SSIs, the integration of such real-time monitoring technologies represents a valuable market opportunity for advancing infection control strategies and improving patient outcomes in surgical settings.

Restraints/Challenges

• High Costs Associated With Advanced Infection Control

The high costs associated with advanced infection control products and technologies can be a substantial barrier for healthcare facilities with limited budgets. For instance, sophisticated systems such as automated UV-C disinfection units and advanced air filtration systems can be prohibitively expensive, especially when considering the additional costs for installation, maintenance, and staff training. Smaller or financially constrained healthcare facilities may find these expenses challenging to manage, which can limit their ability to adopt essential infection control measures and, consequently, affect patient safety and care quality.

• Emergence Of Antibiotic Resistance

Antibiotic resistance presents a critical challenge in infection control, as the emergence of resistant pathogens reduces the efficacy of standard prophylactic measures. For instance, the Centers for Disease Control and Prevention (CDC) reports that over 2.8 million people in the U.S. are affected by antibiotic-resistant infections each year, with more than 35,000 fatalities. Methicillin-resistant Staphylococcus aureus (MRSA) is a prominent instance of such issue, known for its resistance to commonly used antibiotics, which exacerbates the difficulty in controlling infections and underscores the urgent need for enhanced infection control practices and the development of new antimicrobial agents. The increased prevalence of such resistant strains complicates infection control efforts, making it more difficult to manage and prevent surgical site infections effectively, and necessitates the development of alternative strategies and new antimicrobial agents. Consequently hampering the surgical site infection control market.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Surgical Site Infection Control Market Scope

The market is segmented on the type of infection, procedure, product, end users. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type of Infection

• Deep Incisional SSI (Surgical Site Infection)
• Organ or Space SSI
• Superficial Incisional SSI

Procedure

• Caesarean Section
• Gastric Bypass
• Cataract Surgery
• Dental Restoration
• Others

Product

• Surgical Scrubs
• Surgical Irrigation
• Hair Clippers
• Skin Preparation Solution
• Surgical Gloves
• Medical Nonwovens
• Surgical Drapes
• Manual Reprocesses Solution
  • Disinfectants
  • Hand Disinfectants
• Others

End Users

• Ambulatory Surgical Centres
• Hospitals
• Clinics
• Others

Surgical Site Infection Control Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type of infection, procedure, product, end users.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the surgical site infection control market, driven by advanced healthcare infrastructure and increasing awareness about the critical need to manage surgical site infections effectively. Additionally, the region benefits from significant investments in infection prevention technologies and stringent regulatory standards, further fueling its dominance.

The Asia-Pacific region is expected to exhibit the highest growth rate during the forecast period, driven by an increase in surgical procedures due to the rising prevalence of chronic diseases. Additionally, improving healthcare infrastructure and growing investments in medical technology are further contributing to the region's market expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Surgical Site Infection Control Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Surgical Site Infection Control Market Leaders Operating in the Market Are:

• 3M (U.S.)
• BD (Becton, Dickinson and Company) (U.S.)
• ANSELL LTD. (Australia)
• Sotera Health (U.S.)
• Medtronic (Ireland)
• Belimed AG (Switzerland)
• BIOMÉRIEUX (France)
• Getinge (Sweden)
• STERIS (U.S.)
• Lac-Mac Limited (Canada)
• Pacon Manufacturing (U.S.)
• AMERICAN POLYFILM, INC. (U.S.)
• Johnson & Johnson Services, Inc. (U.S.)
• Covalon Technologies Ltd. (Canada)
• Stryker (U.S.)
• Mölnlycke AB (Sweden)
• Prescient Surgical (U.S.)
• PAUL HARTMANN AG(독일)

수술 부위 감염 관리 시장의 최신 동향

• 2022년 4월, Mölnlycke는 말레이시아에 새로운 수술용 장갑 공장을 건설하여 글로벌 입지를 확대했습니다. 이 전략적 움직임은 회사의 생산 역량을 강화하여 포트폴리오의 핵심 제품인 Biogel 장갑에 대한 증가하는 수요를 충족할 수 있도록 하는 것을 목표로 합니다.
• 2022년 3월, Invenio는 수술 중 의료 전문가의 보호와 편안함을 강화하도록 설계된 V90 수술 가운 시리즈를 출시했습니다. 이 새로운 시리즈는 고품질의 신뢰할 수 있는 의료복을 제공하려는 Invenio의 노력에서 한 걸음 더 나아간 것을 나타냅니다.

SKU-35574